Multiple Myeloma and Diabetes | Zendy

Zeinab A. Issa | Zendy; Mira S. Zantout | Zendy; Sami T. Azar | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Multiple Myeloma and Diabetes

Author(s) -

Zeinab A. Issa,

Mira S. Zantout,

Sami T. Azar

Publication year - 2011

Publication title -

isrn endocrinology

Language(s) - English

Resource type - Journals

eISSN - 2090-4649

pISSN - 2090-4630

DOI - 10.5402/2011/815013

Subject(s) - multiple myeloma , diabetes mellitus , concomitant , medicine , bone marrow , plasma cell myeloma , plasma cell , oncology , endocrinology

Multiple myeloma is a malignant plasma cell disorder that accounts for approximately 10% of all hematologic cancers. It is characterized by accumulation of clonal plasma cells, predominantly in the bone marrow. The prevalence of type 2 diabetes is increasing; therefore, it is expected that there will be an increase in the diagnosis of multiple myeloma with concomitant diabetes mellitus. The treatment of multiple myeloma and diabetes mellitus is multifaceted. The coexistence of the two conditions in a patient forms a major challenge for physicians.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research